Canada’s healthcare fails heart disease fight
Canada’s cardiac care system responds only after symptoms appear. Tests and interventions follow, but heart disease develops over years, often without warning.
This approach carries consequences. Heart disease is the country’s second-leading cause of death and a top reason for hospital stays. The system still focuses on reactions rather than early detection.
Prevention requires more than intentions
Most cardiac care depends on single moments: a blood-pressure reading, an ECG, or an imaging scan. These tools matter, yet they capture only a snapshot. They don’t always reveal whether a patient’s condition is worsening between visits.
A layer of care is needed between appointments and hospital tests—portable, repeatable measurements that track changes over time. The aim isn’t to replace diagnostics but to spot high-risk groups where the question shifts from “What’s happening now?” to “What’s changing?”
The gap is real. A national survey found 17% of Canadians lack a regular family doctor. Even among those with access, only 37% could secure an urgent appointment the same or next day. Satisfaction with the system stood at 28%.
A prevention model built on repeated clinic visits and specialist tests can’t work when timely access is scarce. The answer isn’t more data but better use of it. The focus should be on turning measurements into useful insights: identifying who’s stable, who needs closer watch, and who requires advanced testing.
Technology can help, not replace
New tools are emerging to address this need. Seismocardiography (SCG) records tiny chest vibrations caused by the heart’s movement. One device, Recordis, is a portable, non-invasive platform from LLA Technologies. It gathers standardized cardiac data for clinicians to review, though it doesn’t replace echocardiography or other tests.
The concept extends beyond the sensor. It involves creating a continuous layer of cardiac data between visits. The technology supports existing tests by offering repeatable measurements that establish baselines and monitor trends.
The issue isn’t unique to Canada. Health systems globally face the challenge of managing chronic diseases in aging populations while relying on structures designed for single encounters. The difficulty isn’t just developing tools but ensuring systems can evaluate, adopt, and fund them.
Provinces and health authorities should launch structured pilots for these technologies. They must define patient groups, clinical goals, and clear escalation pathways from the start. The priority should be reliability, ease of use, fairness, and whether the data improves care—not just innovation.
Canada doesn’t face a choice between trusted diagnostics and new tools that expand their reach. The system needs both. Waiting for symptoms to trigger costly responses isn’t prevention. Heart disease progresses steadily. The care model must do the same.
Patients who struggle to access regular check-ups may find support through alternative monitoring methods that bridge gaps in traditional care.
